Program Description: 

This educational activity is designed to provide a learning environment that provides interactive discussions on up to date medical information, treatment plans, options and protocols, along with the risks, benefits and outcomes of treatment on adult musculoskeletal oncology patients. This is a discussed in a multidisciplinary format that creates a well rounded unbiased discussion amongst colleagues.  It creates an environment for dynamic discussion and debates on patient care and the treatment resources available. It provides the opportunity for consistent tailored individual treatment protocols per patient.

Synopsis:

What is the clinical/research/teaching/administrative issue you want to address?

  • Discuss treatment plans/options/protocols for newly diagnosed and /or established adult musculoskeletal oncology patients
  • Discuss treatment outcomes in comparison to the standard of care in evidence based medicine
  • Collaborate research efforts and establish research studies based on findings
  • Continue strengthening the multidisciplinary relationships that have evolved over the many years since this tumor board was established.  These relationships continue to provide new collaborations, increased respect, referrals, utilization of treatment resources, and consistent continuity of care.

    ​Adult musculoskeletal oncology patients represent a unique spectrum of cancer patients that are treated as an individual with a tailored evidence-based medicine approach. This approach is based on proven outcomes of treatment protocols, literature evaluations and research outcomes which are then applied to the patient’s protocol. This workshop creates a collaboration of multidisciplinary providers to create plans of treatment and continuity of care between disciplines, while keeping in mind the most up to date trends, strategies, protocols, and clinical trials. This workshop discusses the diverse treatment options available at our treatment center. We want to create relationships and consistent outcomes.
    • Our own research studies are showing patient outcomes (survival, complications, etc) data that is either equal or better in comparison to other published Sarcoma Centers in the country
    • Collaboration on a multidisciplinary level has shown that consistency and continuity of care has improved the direct care/outcome of the patient and created a relationship/respect between disciplines
    • Evidence based medicine approach based on the individual outcomes of each patient reviewed at tumor board in comparison to the literature

Activity Director(s)Don Hackbarth, MD, David King, MD and Lori Hollingsworth-Burds, PA-C

In accordance with the ACCME policy on relevant financial disclosure, the following planners disclosed that they have the following commercial interests. These relationships were reviewed via the MCW conflict of interest resolution process and resolved. 
Dr. D. Hackbarth, Musculoskeletal Transplant Foundation, Board of Directors
Dr. J.C. Neilson, Musculoskeletal Transplant Foundation, Board of Trustees
Dr. S. Tutton, Benvenue, Consultant

All others in control of content had NO relevant financial relationships to disclose.
Drs. K. Baynes, M. Bedi, G. Carrera, R. Cerniglia, J. Charlson, M. Du Bois, S. Erickson, D. King, J. LoGiudice, A. MacKinnon, R. Mannem, J. Neilson, C. Johnstone, D. Johnstone, F. Johnston, P. Rossi, S. Suster, K. Turaga, S. Tutton, L. Hollingsworth-Burds PA-C, S. Veenendaal PA-C, J. Waugh APNP MSN, K. Horness PA-C.

NCCN and other national guidelines are used in patient treatment planning unless otherwise stated by the physician

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0  AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

CME Coordinator Contact Information

Name: 
Lori Hollingsworth-Burds PA-C
Phone number: 
+1 (414) 805-0122
Series date: 
Friday, January 1, 2016 - 12:00am to Tuesday, January 31, 2017 - 12:00am
Series location: 
Froedtert Hospital
9200 W. Wisconsin Ave
Cancer Center
Milwaukee, WI 53226
United States

Sessions

Session Datesort descending
16102 musculoskeletal oncology tumor board January 6, 2016 01/06/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board January 13, 2016 01/13/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board January 20, 2016 01/20/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board January 27, 2016 01/27/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board February 3, 2016 02/03/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board February 10, 2016 02/10/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board February 17, 2016 02/17/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board February 24, 2016 02/24/2016 - 7:30am to 8:30am
16102 Musculoskeletal Oncology Tumor Board March 2, 2016 03/02/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board March 16, 2016 03/16/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board March 23, 2016 03/23/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board March 30, 2016 03/30/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board April 6, 2016 04/06/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board April 13, 2016 04/13/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board April 20, 2016 04/20/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board April 27, 2016 04/27/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board May 4, 2016 05/04/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board May 18, 2016 05/18/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board May 25, 2016 05/25/2016 - 7:30am to 8:30am
16102 Musculoskeletal Oncology Tumor Board June 1, 2016 06/01/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board June 8, 2016 06/08/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board June 22, 2016 06/22/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board June 29, 2016 06/29/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board July 6, 2016 07/06/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board July 13, 2016 07/13/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board July 20, 2016 07/20/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board July 27, 2016 07/27/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board August 3, 2016 08/03/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board August 10, 2016 08/10/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board August 17, 2016 08/17/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board August 24, 2016 08/24/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board August 31, 2016 08/31/2016 - 7:30am to 8:30am
16102 Musculoskeletal Oncology Tumor Board September 7, 2016 09/07/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board September 14, 2016 09/14/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board September 21, 2016 09/21/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board September 28, 2016 09/28/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board October 5, 2016 10/05/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board October 12, 2016 10/12/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board October 19, 2016 10/19/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board October 26, 2016 10/26/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board November 2, 2016 11/02/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board November 9, 2016 11/09/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board November 16, 2016 11/16/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board November 23, 2016 11/23/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board November 30, 2016 11/30/2016 - 7:30am to 8:30am
16102 Musculoskeletal Oncology Tumor Board December 7, 2016 12/07/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board December 14, 2016 12/14/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board December 21, 2016 12/21/2016 - 7:30am to 8:30am
16102 musculoskeletal oncology tumor board December 28, 2016 12/28/2016 - 7:30am to 8:30am